Anti-Inflammatory Effect of a Peptide Derived from the Synbiotics, Fermented <i>Cudrania tricuspidata</i> with <i>Lactobacillus gasseri</i>, on Inflammatory Bowel Disease

<div>Histopathological features of jejunum of the IBD group of mice treated with PBS (a; IBD-PBS-positive group), probiotics (b; IBD-Pro), synbiotics (c; IBD-Syn), peptide 1 (d; IBD-Pep 1), and peptide 2 (e; IBD-Pep 2). Hematoxylin and eosin- (H&amp;E-) stained sections of a mouse large intestine are shown. Black arrows indicate inflammation of the colitis mucosa. Magnifications: ×200.</div>

Mediators of Inflammation

fig4

Figure 4

Figure 4: Anti-Inflammatory Effect of a Peptide Derived from the Synbiotics, Fermented <i>Cudrania tricuspidata</i> with <i>Lactobacillus gasseri</i>, on Inflammatory Bowel Disease 

Figure 4 | Anti-Inflammatory Effect of a Peptide Derived from the Synbiotics, Fermented Cudrania tricuspidata with Lactobacillus gasseri, on Inflammatory Bowel Disease 